PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 3, 2025Journal of Translational Medicine0 citationsOpen Access

Crosstalk between lymphatic system and synovial inflammatory cells in osteoarthritis: molecular mechanisms and potential cell-based therapies

View Full Paper
ZWZeng WangJXJingyuan XiangYLYang Liu

Key Points

  • Abnormalities in the lymphatic system contribute to the progression of osteoarthritis through disrupted joint homeostasis.
  • Key mechanisms include macrophage polarization and regulatory T cell dysfunction, emphasizing the immune response in osteoarthritis.
  • Targeting the synovial lymphatic system with cell-based therapies shows promise in restoring its function and treating osteoarthritis.
  • Mesenchymal stem cells and therapies involving regulatory T cells are identified as leading strategies to enhance lymphatic flow.

Abstract

The lymphatic system plays a significant part in interstitial fluid balance and immune surveillance throughout the whole body. In addition, recent studies have elucidated the role of the lymphatic system in maintaining the normal function of joints, and its dysfunction is related to the pathogenesis of osteoarthritis (OA). In this review, we described the composition and function of the lymphatic system in the knee joints and summarized the research progress of lymphatic networks in the development of OA. The synovial lymphatic system (SLS) is the most well-characterized lymphatic network, and we elaborated the pathological changes of SLS which resulted in the disturbance of knee joint homeostasis and the progression of OA. We summarized the underlying molecular mechanisms of lymphatic disorders and focused on the crosstalk between the SLS and synovial inflammatory cells, especially the abnormal macrophage polarization and regulatory T cells dysfunction. Cell-based therapies have been proven to restore lymphatic function. This review proposed potential cell-based therapies to treat OA by targeting the SLS, and mesenchymal stem cells and Tregs based therapies are currently the most promising approaches to treat OA by restoring lymphatic flow.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/68dfe935daa1363beb049c2chttps://doi.org/10.1186/s12967-025-07080-3
Ask AI
Helpful
Bookmark
Share
View Full Paper